3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
17
Fallopian Tube Neoplasms
15
Breast Neoplasms
7
Sarcoma
5
Neoplasm Metastasis
4
Carcinoma, Ovarian Epithelial
4
Neoplasms
3
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Multi-centric Castleman's Disease
2
Hodgkin Disease
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Cancer Recurrent
1
Osteosarcoma
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphadenopathy
1
Interventions
Cyclophosphamide
23
fludarabine
14
Rituximab
14
Specimen Handling
9
Magnetic Resonance Spectroscopy
8
Doxorubicin
7
pirtobrutinib
6
Vincristine
6
Prednisone
6
polatuzumab vedotin
5
obinutuzumab
5
Biopsy
5
zanubrutinib
4
glofitamab
4
Nivolumab
4
Etoposide
4
Dexamethasone
4
tazemetostat
3
tafasitamab
3
pembrolizumab
3
ibrutinib
3
fludarabine phosphate
3
acalabrutinib
3
Leukapheresis
3
Bendamustine Hydrochloride
3
venetoclax
2
pomalidomide
2
loncastuximab tesirine
2
etoposide phosphate
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
liposomal doxorubicin
×
90 days
×
Clear all
No trials found.